PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos
Biomolecules and Biomedicine · 2025
DOI: 10.17305/bb.2025.12533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2025. Verfasst von Huiming Nong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Province, China. Hauptthemen laut MEDLINE: Cisplatin, Poly (ADP-Ribose) Polymerase-1, Apoptosis Inducing Factor, Phenanthrenes. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor PJ34 acts as an anti-inflammatory and neuroprotective agent by modulating parthanatos. This study aimed to explore the protective effects of PJ34 against cisplatin-induced injury in auditory cells and to elucidate its underlying mechanism of action. Flow cytometry and immunofluorescence were employed to detect apoptosis in HEI-OC1 and ovarian cancer cell lines. Additionally, immunofluorescence and Western blotting were used to assess changes in the expression of related proteins, including cleaved Caspase-3, PARP-1, and cytosolic apoptosis-inducing factor (AIF), across the groups. Mitochondrial membrane potential (MMP) levels were measured using the MMP assays, and reactive oxygen species (ROS) levels were assessed by MitoSox red staining. Our results indicate that treatment with 30 μM cisplatin activates cleaved Caspase-3, promotes PARP-1 overexpression, and facilitates AIF nuclear translocation, leading to decreased MMP and increased ROS accumulation, which ultimately triggers auditory cell death. Treatment with 2.5 μM PJ34 mitigated PARP-1 overexpression and AIF nuclear translocation following cisplatin exposure, reduced the decline in MMP, and decreased ROS accumulation, thereby alleviating damage to auditory cells. Conversely, PJ34 enhanced the damaging effects of cisplatin on ovarian cancer cell lines. In conclusion, our findings suggest that PJ34 may reduce cisplatin-induced hair cell death by regulating PARP-1-mediated parthanatos. Notably, PJ34 shows promise as a potential novel therapeutic agent for the prevention and/or treatment of cisplatin-induced ototoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Province, China.
- Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Province, China.
Zitieren
APA
Nong, H., Zhang, X., Yuan, Y., Zhang, J., Zhao, J., & Cao, Z. (2025). PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2025.12533
Vancouver
Nong H, Zhang X, Yuan Y, Zhang J, Zhao J, Cao Z. PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos. Biomolecules and Biomedicine. 2025. doi:10.17305/bb.2025.12533
BibTeX
@article{Nong2025,
author = {Nong, Huiming and Zhang, Xiru and Yuan, Yingxue and Zhang, Junhong and Zhao, Jingyi and Cao, Zhixin},
title = {PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos},
journal = {Biomolecules and Biomedicine},
year = {2025},
doi = {10.17305/bb.2025.12533}
}
EUVIMED